In the B16 melanoma model, which has been characterized to be MHC class I-defective and highly refractory to ICIs (40), Imprime combined with the anti-Tyrp1 Ab TA99 almost completely prevented outgrowth of lung metastases. The gene discussed is TYRP1; the disease is melanoma.